Answers are grounded in this paper and cite their sources.
This analysis demonstrates oxycodone's unique properties affecting analgesia in various populations, suggesting why it thrives in the opioid market.
As morphine, oxycodone is a m-opioid receptor agonist with a significantly different pharmacokinetic profile compared with morphine. It seems that oxycodone is able to compensate its lower binding affinity for the m-opioid receptor compared with that of morphine by active transport to the central nervous system. Although the analgesic properties of oxycodone are mainly due to its own activity, cytochrome (CYP) inhibitors and inductors may change oxycodone-induced analgesia as a result of higher or lower, respectively, oxycodone concentrations.
No takes yet. Share an insight, caveat, or question.
Lemberg et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: